Response to ‘Lack of reversibility for NOACs’ | QScience.com

1887

Volume 2014, Issue 1

ISSN: 2305-7823
EISSN:

oa Response to ‘Lack of reversibility for NOACs’
Authors: Riyaz A Kaba^1,2,3,4, Omar Ahmed¹, Douglas Cannie²
View Affiliations Hide Affiliations

Affiliations: ¹ ¹Ashford & St Peter's Hospitals NHS Foundation Trust, Chertsey, UK ² ²Epsom General Hospital NHS Trust, Epsom, UK ³ ³St George's Hospital NHS Trust, London, UK ⁴ ⁴Royal Holloway, University of London, UK
Source: Global Cardiology Science and Practice, Volume 2014, Issue 1, Jun 2014,
DOI: https://doi.org/10.5339/gcsp.2014.2
- Received: 27 January 2014
- Accepted: 29 January 2014
- Published online: 01 June 2014

Preview this article:

© 2014 Kaba, Ahmed, Cannie, licensee Bloomsbury Qatar Foundation Journals.

Article metrics loading...

/content/journals/10.5339/gcsp.2014.2

2014-06-01

2024-04-19

Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2014/1/gcsp.2014.2.html?itemId=/content/journals/10.5339/gcsp.2014.2&mimeType=html&fmt=ahah

References

Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P. EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary. Eur Heart J. 2013; 34:27:2094–2106.
[Google Scholar]
van Ryn J, Litzenburger T, Gan G, Coble K, Schurer J. In Vitro Characterization, Pharmacokinetics and Reversal of Supratherapeutic Doses of Dabigatran-Induced Bleeding in Rats by a Specific Antibody Fragment Antidote to Dabigatran. Stroke. 2013; 44::AWP261.
[Google Scholar]

http://instance.metastore.ingenta.com/content/journals/10.5339/gcsp.2014.2

Article Type: Letter to the Editor

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error